Interview: Jacob Lee – Co-Founder & CEO, DTCO, Taiwan

Jacob Lee, co-founder and CEO of DTCO, a Taiwan-based company focused on industrial blockchain services, documents the disruptive impact that the development of the blockchain technology in the healthcare and life sciences sectors could entail for both patients and healthcare providers. He also provides insights into the in-house development of bioIPSeeds, which proudly stands as the first application of the blockchain technology in the life sciences field and aims to revolutionize the collaboration between academia and the global healthcare industry. You recently described the development of the blockchain technology as a crucial milestone marking a fourth industrial revolution. Why do you believe blockchain holds such a promising and impactful potential?
"I expect the development of blockchain technology to be as disruptive as the dawn of the Internet."
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report